Second Sight Medical Products Inc
EYESW · NASDAQ
12/31/2024 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$23,486 | -$9 | -$15 | -$33,592 |
| Dep. & Amort. | $400 | $0 | $164 | $397 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,610 | $0 | $421 | $2,925 |
| Change in WC | $0 | -$421 | -$3,744 | $37 |
| Other Non-Cash | $690 | $421 | -$13,648 | $2,604 |
| Operating Cash Flow | -$20,786 | -$9 | -$16,822 | -$27,629 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$556 | -$0 | -$330 | -$493 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $13,687 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$13,687 | $0 | $398 | $0 |
| Investing Cash Flow | -$556 | -$0 | $68 | -$493 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $160 | $78 | $6,679 | $34,505 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $19,054 | $76 | $8,598 | $34,989 |
| Financing Cash Flow | $19,054 | $76 | $8,598 | $34,989 |
| Forex Effect | -$14 | $0 | $6 | -$11 |
| Net Chg. in Cash | -$2,302 | $66 | -$8,150 | $6,856 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $21,992 | $3,177 | $11,327 | $4,471 |
| End Cash | $19,690 | $3,243 | $3,177 | $11,327 |
| Free Cash Flow | -$21,342 | -$9 | -$17,152 | -$28,122 |